Sandoz, the generic drug business being spun out by Novartis, announced plans on Thursday to build a new production plant in Slovenia to increase its capacity to make biosimilar drugs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,